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Abstract
Background: The polarization of somite-derived sclerotomes into anterior and posterior halves
underlies vertebral morphogenesis and spinal nerve segmentation. To characterize the full extent
of molecular differences that underlie this polarity, we have undertaken a systematic comparison
of gene expression between the two sclerotome halves in the mouse embryo.
Results: Several hundred genes are differentially-expressed between the two sclerotome halves,
showing that a marked degree of molecular heterogeneity underpins the development of somite
polarity.
Conclusion: We have identified a set of genes that warrant further investigation as regulators of
somite polarity and vertebral morphogenesis, as well as repellents of spinal axon growth. Moreover
the results indicate that, unlike the posterior half-sclerotome, the central region of the anterior-
half-sclerotome does not contribute bone and cartilage to the vertebral column, being associated
instead with the development of the segmented spinal nerves.
Background
The subdivision of embryonic tissues into serial repeat-
units, or segments, is a fundamental patterning process in
early vertebrate development, and is most prominent in
the formation of the mesodermal somites. Somites arise
as paired epithelial spheres that bud off from the undiffer-
entiated paraxial mesoderm (presomite mesoderm, PSM)
flanking the notochord, and subsequently give rise to sev-
eral tissues including the segmented axial skeleton and
epaxial musculature of the adult organism [1,2].
The formation and development of somites involves the
superposition of two orthogonal patterning systems act-
ing within the paraxial mesoderm. The first operates along
the anterior-posterior (A-P) axis and is intrinsic to the
paraxial mesoderm, resulting in individuation of the
somites and their concomitant polarization into anterior
and posterior halves (Figure 1). Somite formation is
dependent on a molecular 'clock' within the PSM that
generates periodic expression of genes including the
notch, wnt and fibroblast growth factor (FGF) signalling
pathways [3-5]. These cyclical gene expression patterns are
superimposed on a regressing, longitudinal gradient of
FGF expression along the A-P axis that results in the co-
ordinated maturation of groups of PSM cells into each
successive somite. Somite polarity is determined within
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the anterior PSM by a complex feedback mechanism
mediated by notch signalling, the transcription factors
tbx6 and mesp2, and ripply2, a negative regulator of
mesp2 [6-11].
A second patterning system operates after somite forma-
tion, within both dorso-ventral and medio-lateral axes,
and involves the early antagonistic and synergistic action
of signalling molecules, such as sonic hedgehog, noggin
and wnt, that originate outside of the paraxial mesoderm
[12-15]. This separates the somite into two major sub-
components, the sclerotome (skeletal/vertebral precursor
cells) and the dermamyotome (muscle and dermis precur-
sors). It also subdivides the sclerotome into further
regions that are distinguished in terms of both morpho-
genesis and gene expression (Figure 1). These include the
ventral peri-notochordal sclerotome that forms the verte-
bral bodies and intervertebral discs; the central (mid-
dorso-ventral) sclerotome that generates the vertebral
pedicles, transverse processes and most of the neural
arches; and the dorsal sclerotome that gives rise to the ver-
tebral spinous processes [2,12,13]. In keeping with the
differing morphogenesis of these regions, their chondro-
genesis is controlled by distinct upstream mechanisms
[12,13]. For example, central sclerotome differentiation is
regulated by uncx4.1, and uncx4.1-deficient mice exhibit a
complete loss of the central sclerotome-derived vertebral
components mechanisms, while ventral sclerotome is
independently regulated by pax1 and pax9, thus ventral
development is unperturbed in uncx4.1 mutants [16-18].
Somite patterning and fate Figure 1
Somite patterning and fate. Somite development involves two patterning systems operating along the A-P and D-V axes. (i) 
Unsegmented presomite mesoderm and nascent somites showing the oscillations and gradients of gene activity that determine 
A-P polarity prior to overt somite formation (green: anterior half-somite; red: posterior half-somite). (ii) Transverse section 
through an A-half-epithelial somite (esm, left) and a differentiated somite (right). Patterning along the D-V axis sub-divides the 
somite into dermatome (dr), myotome (m) and sclerotome (s). The sclerotome is further sub-divided into ventral (v), central 
(s, red) and (d) dorsal regions. (iii) Representation of two somites viewed laterally, showing the central sclerotome A-P sub-
division. Only the anterior-half (green) is permissive for PNS components. (iv) In differentiated vertebrae, posterior-central 
sclerotomes form the paired transverse processes and pedicles of the neural arches (red) that encase the spinal cord and pro-
vide attachment points for epaxial muscles. Anterior central-sclerotome derivatives (green) contribute to peripheral nerve 
sheaths and prefigure the positions of the intervertebral foraminae (ivf). Spinous process (sp), intervertebral disc (ivd), verte-
bral body (vb).BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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The co-ordinated action of these patterning systems creates
a set of volume elements in the sclerotome that generate the
mature axial skeleton via a process termed resegmentation
[19-22]. The alternating arrangement of A- and P-ventral-
half-sclerotomes pre-configures serial repetition of the ver-
tebral bodies and intervertebral discs, and generates a
weight-bearing yet flexible vertebral column that supports
the head and trunk. The A- and P-central half-sclerotomes
form the vertebral canal, which houses and protects the spi-
nal cord, and molecular differences between the two halves
of the sclerotome are critical for this process. The P-central-
half-sclerotomes, which form the walls of the canal (verte-
bral pedicles, transverse processes and neural arches), also
impart segmental barriers to emigrating neural crest cells
and spinal axon growth cones, thereby imposing secondary
segmentation on the developing peripheral spinal nerves
[23-28]. By contrast, the A-central-half-sclerotomes form a
permissive environment in which neural crest cells can dif-
ferentiate to form the segmental dorsal root ganglia, and
through which further neural crest cells, as well as motor
and primary sensory axons, can navigate. The A-central-
half-sclerotomes ultimately yield the intervertebral forami-
nae, ensuring that the spinal nerves can enter and exit the
spinal cord unimpeded by the walls of the vertebral canal;
they also contribute cells to the endoneurium and perineu-
rium of the spinal nerves [2,12,29]. In sum, somite polarity
ensures optimum mechanical protection of the spinal cord
while simultaneously permitting movement of the verte-
brate trunk and bidirectional nervous transmission
between the spinal cord and the periphery. Recently,
another functional role of A-P somite polarity has been
uncovered, as definitive aortic endothelial cells have been
shown to originate from the P-half-somite [30].
While the normal development and function of the verte-
brate trunk is critically dependent on correct somite polar-
ity, it remains unclear how the molecular differences
between A- and P-cells are transcriptionally-regulated.
Moreover, while a substantial degree of molecular com-
plexity is likely to distinguish A- from P-cells, and several
such differences have been documented, the detailed
molecular components and their interactions are
unknown [25,27]. Identifying such differences is a prereq-
uisite for a sophisticated understanding of vertebral col-
umn genetics and the genesis of vertebral anomalies, as
well as for future stem cell and tissue engineering strate-
gies to repair the injured or diseased vertebral column. As
a first step towards defining the full range of the molecular
differences between A- and P-half sclerotomes, we have
adopted a novel gene expression-profiling strategy based
on the analysis of expression microarrays of micro-dis-
sected mouse sclerotome components. Our results high-
light the degree to which somite polarity at the cellular
level is reflected by extensive molecular differences
between the two somite halves.
Results
To identify novel genes involved in the establishment and
maintenance of the anterior-posterior (A-P) difference
between the two halves of the sclerotome, we adopted a
microarray-based expression-profiling approach. Pilot
experiments indicated that ~300 pg of total RNA could be
isolated per sclerotome half (estimated as ~150 cells).
Multiple sclerotome-halves were dissected as described in
the Methods and pooled as depicted in Figure 2A. The
pooling strategy was used for two reasons: first, to avoid
inefficient amplification of sub-nanogram quantities of
RNA, and second, to minimize the variation in gene
expression that might be caused by position-specific and
somite-stage-specific differences in the samples.
To generate sufficient material for profiling by microarray,
a global amplification method was designed to overcome
the detrimental effects of high-cycle-number PCR amplifi-
cation on transcript representation, and to alleviate ineffi-
cient amplification by in vitro transcription in the
nanogram range (Figure 2B) [31]. This method employs
an initial low-cycle-number PCR amplification using
strand-switching PCR amplification approaches, followed
by linear in vitro transcription and subsequent labelling of
the amplified population. Amplified RNA was hybridised
to the mouse genome 430 2.0 Genechip (Affymetrix) as
described in the Methods. The raw image files and com-
puted intensity data are available from ArrayExpress
(accession number: E-MEXP-913 http://www.ebi.ac.uk/
arrayexpress. To ensure the efficacy of downstream analy-
sis, all array data were subjected to quality control steps
prior to further analysis (see Methods).
Differential gene expression in somites
To confirm that the embryo dissection and subsequent
processing had accurately generated anterior- and poste-
rior-half-sclerotome populations without significant
cross-contamination, we analysed the microarray data for
expression of genes that have been shown unequivocally
in previous studies to be differentially-expressed between
A- and P-half-sclerotome (see [25] for general review). The
expression measures within the array data for 11 known
differentially-expressed genes (efnb2, ephb3, fgf3, fgfr1,
meox1, nmyc1, sema3a, sema3f, spon1, tbx18, uncx4.1: see
Additional File 1) were used for agglomerative hierarchi-
cal clustering of the arrays within the R statistical environ-
ment (see Methods). This procedure makes no
assumptions about the identity of individual arrays as
anterior or posterior and allows monitoring of the related-
ness of the arrays to each other. The dendrogram in Figure
3 resulting from this analysis shows that each array sepa-
rates into one of two distinct groups corresponding to its
origin as A- or P-half-sclerotome. This pattern is distinct
from that generated by clustering all genes on the array,
and from that generated by clustering selected probe dataBMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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(A) Half-sclerotome dissection Figure 2
(A) Half-sclerotome dissection. Strips corresponding to the 10–18th most recently formed somites (S10-S18) were iso-
lated from mouse embryos at TS15 (9.5–10.25 d.p.c.). Individual A- (green) or P-sclerotome (red) halves were dissected and 
pooled for further processing. V, ventral; D, dorsal; A, anterior; P, posterior. (B) Amplification of sclerotome RNA. (i) 
Total RNA was purified individually from pools of A- or P-half-sclerotomes. (ii) First strand cDNA was synthesized by reverse 
transcriptase (blue) using a modified Clontech SMART primer containing oligo (dT), a T7 RNA polymerase promoter and an 
universal primer (UP). (iii) The template-independent addition of 3' C residues allows second strand synthesis by strand-
switching of reverse transcriptase using a second UP bearing G residues. (iv) Global cDNA amplification by limited PCR cycles 
using a UP alone. (v, vi) Further amplification, and generation of antisense-labelled probe by in vitro transcription using T7 
polymerase (red) for hybridization to microarraysBMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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sets that are not differentially-expressed (see Additional
File 2). Overall, these results indicate that all A-half-scle-
rotome samples are more closely related to all other such
samples, and that all P-half-sclerotome samples are like-
wise more closely related to each other, so any cross-con-
tamination is likely to be insignificant. Differences
between the two groups of array data are likely, therefore,
to reflect significant molecular differences between A- and
P-sclerotome-halves.
Having confirmed the distinct anterior and posterior iden-
tity of the dissected samples, we estimated next the total
number of genes differentially-expressed between ante-
rior- and posterior-sclerotome-halves. We first ranked
transcripts in terms of statistical certainty of differential
expression between A- and P-halves using Welch's t-test,
and then examined the transcript distribution of the 11
known differentially-expressed genes described above.
While many of these transcripts are evenly distributed
across the rank-ordered transcript range, it is notable that
more than one third are found at the low end of the p-
value distribution, and that this is not observed with non-
differentially-expressed somite-related genes (Additional
File 3). This suggests that our array analysis has a high
probability of revealing differential expression. Further-
more, visual inspection of the rank-order (Additional File
1) suggests that there are as many as 700 genes with a high
probability of differential expression. To provide a more
accurate estimate of the total number of differentially-
expressed genes and additional statistical validation,
Fisher's exact score was used to determine the significance
of enrichment of differentially-expressed genes within
increasing group sizes amongst the rank-ordered tran-
scripts relative to the genome as a whole. Figure 4 demon-
strates that the lowest p-value, which provides a
minimum estimate of the total number of differentially-
expressed genes between the anterior and posterior scle-
rotomes halves, corresponds to ~175 transcripts. Further
examination of this graph (Additional File 4) indicates
again that there may be as many as ~650 differentially-
expressed genes, as p-values rise very rapidly for pool sizes
greater than 650 (see Additional Files 5 and 6 for lists of
transcripts 1–175 and 176–850 respectively).
Of the 175 genes, we find that 57 (32.6%) are expressed
in the A-half-sclerotome while 118 (67.4%) are expressed
Clustering of individual arrays with respect to genes known  to shown differentially-expressed in A- or P-half-sclerotomes Figure 3
Clustering of individual arrays with respect to genes 
known to shown differentially-expressed in A- or P-
half-sclerotomes. Dendrogram of agglomerative hierarchi-
cal clustering of individual array hybridization experiments 
based upon expression data for genes previously reported to 
show differentially expression between A- and P-sclerotome-
halves. The arrays cluster into two distinct groups, and con-
firm the original identity of the dissected material as A- or P-
half-sclerotome.
Statistical significance of differential gene expression in the  array data Figure 4
Statistical significance of differential gene expression 
in the array data. Fisher's exact test was used to explore 
the null hypothesis that known differentially-expressed genes 
are not related to their expression values in A- versus P-half-
sclerotome. The y-axis shows the probability (p) that a pool 
of transcripts shows no enrichment of differentially-
expressed genes; the lower the p-value the more likely it is 
to have significant enrichment. The x-axis shows the rank-
ordered pool size of transcripts as determined by statistical 
certainty of differential expression in ascending order. The 
inset shows an expanded view of the rectangle indicated 
close to the origin. The dotted line corresponds to p = 10-9. 
The maximum statistical significance, and thus the minimum 
estimate for the total number of genes that are differentially-
expressed between the two sclerotome halves, is obtained 
with a pool of ~175 transcripts.BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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in the P-half-sclerotome. The relative proportions of A-
and P- specific expression are in keeping with estimates
from the literature suggesting that around 20 markers are
differentially-expressed between A- and P-sclerotome with
~75% showing P-specific expression [25,32]. Overall, this
indicates that there are significant transcriptional differ-
ences between the two somite halves and also reveals a
posterior bias of differential transcriptional activity
between the A- and P-sclerotome-halves (see Discussion).
Our data further indicates that the total number of differ-
entially-expressed genes may be some 8–30-fold higher
than previously reported.
Functional categorisation of candidate genes
To assess whether there are particular molecular processes
significantly associated with either the A- or P-half-scle-
rotome genes, the Database tool for Annotation, Visuali-
zation and Integrated Discovery was used with Gene
Ontology Consortium terms (GO, http://www.geneontol
ogy.org/), biochemical pathways (Kyoto Encyclopedia of
Genes and Genomes, KEGG, http://www.genome.jp/
kegg/) and protein domain family names (PFAM, http://
pfam.sanger.ac.uk/). Additional File 7 lists all resulting
terms for biological processes that show a significant
probability of enrichment relative to the whole genome
for the first 175 genes. While we have focused our discus-
sion on statistically most reliable (p < 10-3) and therefore
necessarily more general categories in the ontological
hierarchies, Additional File 7 presents an extended list of
terms from p < 10-1. Of note is the finding that there is
nearly 2-fold enrichment within the P-half-sclerotome for
expression of 'nuclear proteins' (GOTERM_CC_ALL
nucleus: 30.4%, p = 9.11 × 10-5), much of which appears
attributable to >2-fold over-representation of 'transcrip-
tional regulators' (GOTERM_BP_ALL regulation of tran-
scription: 20%, p = 2.94 × 10-4). Other enriched GO terms
in the P-half include ~2-fold enrichment in genes associ-
ated with 'metabolic regulators' (21.6%, p = 2.60 × 10-4),
'regulation of cellular physiological processes' (25.6%, p =
2.06 × 10-4) and 'nucleic acid binding' (24.8%, p = 1.79 ×
10-4). A similar comparison of PFAM families
(SP_PIR_KEYWORDS) supports such findings and also
reveals several additional enriched categories in the P-
half-sclerotome, including phosphorylation, showing a 3-
fold enrichment (16%, p = 2.07 × 10-5), 'developmental
protein', showing a 4.7-fold enrichment (8%, p = 2.53 ×
10-4) and 'membrane proteins' with a ~1.8-fold enrich-
ment (18.4%, p = ~5 × 10-3). In comparison with the P-
half-sclerotome, the A-half-sclerotome shows little enrich-
ment of functional categories with p < 10-3. Only the GO
term 'regulation of cellular process I' is found with a 2.3-
fold over-representation (24%, p = 8.64 × 10-4). It is of
interest, from casual inspection of probabilities > 10-3,
that there is a posterior enrichment of genes involved in
'axon guidance', as well as 'UDP-glycosyltransferase activ-
ity' which is required for axon repulsion mediated by P-
half-sclerotome cells [23]. As the number of David IDs
associated with these terms is small some caution must be
made in interpretation for less stringent p-values.
While the above analysis compares gene expression in the
A- and P-half-sclerotomes relative to the whole genome,
we also undertook a direct comparison of gene expression
in A- versus P-half-sclerotome. A combination of BLAST
http://www.ncbi.nlm.nih.gov/BLAST/ searches and the
GO database was used to assign a functional term to each
of the 175 genes that are differentially-expressed between
the two sclerotome halves. These terms were then grouped
into 15 different categories (Figure 5). Again, this reveals
a higher proportion of genes involved in transcription
expressed in the P-half-sclerotome relative to the A-half
(19.4% versus 10.6%). Furthermore, the number of P-
half-enriched genes involved in signal transduction is
more than double that for A-half-enriched genes (16.3%
versus 7.6%) and include two members of the wnt family
(wnt5a, nkd2 homolog), two tgf  pathway genes (tgfbr2,
bmp5) and two mapk pathway genes (mapk8, atf2). Figure
5 also shows that there are more than three-fold as many
genes with known developmental functions expressed in
the P half-sclerotome compared with the A-half. In keep-
ing with a bone/cartilage fate for the P-half sclerotome, it
is notable that we find selective expression in the P-half of
the master regulator of chondrogenic differentiation, sox9
[33], as well as bmp5, a member of the bone morphoge-
netic protein family.
Further confirmation of differential gene expression
Of the 11 known differentially-expressed genes, 6
(uncx4.1, meox1, nmyc1, tbx18, sema3a, efnb2) are found
within the top 175 genes in our list. This analysis has
revealed many more differentially-expressed genes, for
which we sought independent confirmation by whole-
mount in situ hybridisation (WISH). Within the list of
175, genes were prioritized according to the significance
of their differential expression, using both Significance
Analysis of Microarrays (SAM) with a false discovery rate
of 10%, and the Bayesian Cyber-T approach, with p < 10-
4. The original Affymetrix probe sequences were obtained
from NetAffx https://www.affymetrix.com/analysis/
netaffx/index.affx, and BLAST was used to map sequences
to Ensembl gene identifiers using the Ensembl genome-
browser http://www.ensembl.org. After cropping the list
of ambiguous and redundant entries, a revised list con-
taining 50 entries was generated. Additionally, the same
analysis was applied to the genes in the range 176–850,
the region over which enrichment remained statistically
highly significant, and generated a further list of 15 genes.
Overall, we generated 41 (82%) WISH probes from the
top 175 genes and 15 (100%) probes from the next 176–BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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850 genes. In situ hybridisation was performed on TS15-
17 (9.5–10.5 d.p.c.) embryos. The results for the top 175
candidates were classified into 4 groups based upon
somite staining pattern: Group 1, unambiguous differen-
tial expression (7 genes, 17%); Group 2, very likely to be
differentially-expressed (8 genes, 19.5%); Group 3, likely
to be differentially-expressed (10 genes, 24.4%); and
Group 4, non-staining or no differential expression (16
genes, 39%); see Figure 6, Table 1, Additional File 8. The
equivalent results for the 176–850 genes are as follows:
Group 1 (2 genes, 13.3%), Group 2 (2 genes, 13.3%),
Group 3 (2 genes, 13.3%), Group 4 (9 genes, 60%). This
shows that even within the range of candidates ranked
from 176–850, we can still detect a similar fraction of
Group 1 genes (unambiguous differential expression)
compared with the candidates ranked from 1–175. In
summary, considering a candidate list from 1–850 as a
whole, revalidation of the microarray candidates by in situ
hybridisation indicates a positive rate of 55.4% for groups
1, 2 and 3 inclusive.
In addition to WISH, we applied a more sensitive, second
revalidation procedure to a subset of these genes. PCR
primers for real-time quantitative PCR (qPCR) were
designed for selected genes in each category, including 9
genes from Group 4 (non-staining or no differential
expression). Overall we obtained 22 pairs of primers that
gave a regression coefficient of >0.99 on a standard curve
of dilution and a single peak on a dissociation curve. Gene
expression was calculated for 3–5 individual A- and P-
half-sclerotomes (dissected as above). Notably, as with
the microarray data, the highest ratios of gene expression
obtained using qPCR in A- and P-halves were for tbx18
and uncx4.1 respectively. The ratios obtained for the most
highly differentially-expressed transcripts within the
microarray data were lower than for qPCR, suggesting that
the RNA amplification in array experiments may result in
underestimation of gene expression differences. Addition-
ally, qPCR with two further control genes, sema3a and
spondin1, confirmed their expression as P-restricted.Of
the 22 genes typed by qPCR, 14 (63%) showed two-fold
or greater differential expression (Figure 7, Additional File
9), while a further 3 genes show smaller but robust differ-
ences between A- and P-half-sclerotome (see Additional
File 10). Most significantly, 6 of the 9 genes assigned to
the 'non-staining/no differential expression' group by
WISH, were re-assigned as differentially-expressed.
Another 2 of these 9 genes were amongst the group of 3
genes showing small but distinct differences between A-
and P-half-sclerotome. This indicates that the initial WISH
screen is likely to underestimate the true proportion of
differentially-expressed genes, which may actually be as
high as 75%. In turn, of the original list of 175 genes, it is
likely that at minimum 130 are differentially-expressed
Functional categories of A- and P-sclerotome-half restricted genes Figure 5
Functional categories of A- and P-sclerotome-half restricted genes. Each A- or P differentially-expressed gene was 
placed into one of fifteen functional categories based on BLAST and GO database descriptors (grey, P-restricted genes; white, 
A-restricted genes). A higher proportion of P-half-sclerotome restricted genes fall into functional categories such as develop-
ment, signal transduction and transcriptional regulation.BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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Whole-mount in situ hybridization of candidate genes differentially-expressed between A- and P-half-sclerotome Figure 6
Whole-mount in situ hybridization of candidate genes differentially-expressed between A- and P-half-scle-
rotome. 56 candidate genes were tested for differential expression in A- and P-sclerotome-halves by whole-mount in situ 
hybridization. The resultant expression patterns were placed into four different groups based upon their certainty of differen-
tial expression. Groups 1–3 represent genes with decreasing certainty of differential expression (group 1, high certainty; group 
3, low certainty), while group 4 genes show no apparent staining or no observed differential expression. Three examples from 
each group are shown: Group 1: bmp5, gpc6, plxna2 (green text); Group 2: crabp1, robo1, sox9 (yellow text); Group 3: mospd2, 
timp3, rab1 (blue text); Group 4: arhgap5, nedd4, slit2 (brown text). Table 1 and Additional File 8 present additional data for the 
remaining 44 genes.
Table 1: Classification of candidate differentially-expressed sclerotome genes as assessed by whole-mount in situ hybridization
Group 1 Group 2 Group 3 Group 4
bmp5, flrt2
gpc6, meox1
nmyc1, plxna2
uncx4.1
[igfbp5 (766) lef1 (297)]
efnb2
acpl2/nm153420
mtdh, rbp1, robo1 rps6 sema3a
sox9
[crabp1 (323)
fap (178)]
anapc4/d5Ertd249e, ets2
fgfr1op, gpr150
mospd2/2410013I23rik
rab1, rab28, timp3, tpr/C77892
trappc6b
[cd44 (535)
Q8C5E4/9430095K15rik (243)]
apg5l, arhgap5, btc
cnot7, d17wsu104e
lxn, narg1, nedd4
nm028130/2610020C11rik
enh/1110001A05rik, nm027740 q8cak8, st13/
3110002K08rik
tbc1d24, tcfap2b
zc3h6/4631426G04rik
[slit2 (851), cd44 (535)
cdc42 (337), col4a5 (271)
dcc (647), ddx3y (344)
eif4e (395), galgt1 (491)
hexb/a930009M04rik (645)]
Expression patterns were classified into 4 groups based upon somite staining: Group 1 (unambiguous differential expression), Group 2 (likely to be 
differentially-expressed), Group 3 (probably differentially-expressed), and Group 4 (non-staining or no differential expression); Results from the 1–
850 candidate range are shown. Genes in the range 176–850, with their respective ranking, are separated by a space and enclosed by square 
brackets (see Figure 6 and Additional File 8 for whole-mount in situ hybridization images for each gene).BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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between A- and P-half-sclerotomes. Moreover, since the
qPCR-positive proportion of candidates within the top
175–850 genes is 15%, the absolute number of differen-
tially-expressed genes is likely to be substantially higher.
Discussion
Recent studies of the molecular basis of somite develop-
ment have emphasized the key roles played by the cyclical
expression of genes in the presomite mesoderm, and also
by counter-gradients along the A-P axis of signalling mol-
ecules [3-5]. In addition, a complex interaction of the
transcription factor genes mesp2, ripply2 and tbx6 has been
shown to establish A-P somite polarity mesp2 [6-11]. Our
study has focussed on events that maintain polarity dur-
ing sclerotome differentiation, after the initial appearance
of somite polarity. Consistent with this, mesp2, ripply2 and
tbx6 do not feature in our gene expression profiles. While
numerous studies have focused on the differential expres-
sion of individual genes within the sclerotome halves,
there has been no systematic attempt to characterize the
overall molecular complexity in this system, and it has
remained unclear whether many more differentially-
expressed genes are required to maintain sclerotome
polarity and differentiation. Furthermore, the molecular
basis of the well-known repulsion of spinal (motor and
sensory) axons by posterior-half-sclerotome has yet to be
fully explained. The present study reveals a surprising
degree of molecular heterogeneity between the two scle-
rotome halves, and highlights the potential complexity
underlying an overtly simple embryonic pattern.
Our approach has been to use microarray technology with
limiting quantities of starting RNA, followed by confirma-
tion of candidacy for differential expression by whole-
mount in situ hybridization and/or qPCR. It is interesting
to compare our data with those of Buttitta et al. [34], who
assessed gene expression in presomitic mesoderm versus
newly-formed somites using much larger amounts of
starting RNA. The numbers of genes identified in the two
studies (several hundred) are broadly comparable, indi-
cating that the use of much smaller starting quantities of
RNA in the present study has not compromised the ability
to detect gene expression differences between highly
related tissues. It is of note that, when WISH is used as a
secondary validation in both studies, there is a compara-
ble reduction in the proportion of genes confirmed as dif-
qPCR analysis of differential expression between sclerotome halves Figure 7
qPCR analysis of differential expression between sclerotome halves. qPCR was used to assess the relative expression 
in A- and P-half-sclerotomes of a selection of candidate genes identified from array and ISH experiments. Data for 11 genes 
with P-half sclerotome enrichment, 3 with A-half enrichment and spondin-1 as a P-half control are shown. Box plots indicate 
dispersion and skewness of the numerical distribution of expression values. qPCR values from individual experiments were 
expressed as a fraction of the highest value obtained for that gene in each half-sclerotome. No shading and grey shading indi-
cates the distribution of A-half and P-half expression respectively. The extent of each box represents the middle 50% of the 
ranked data with the median indicated by a horizontal bar and range by the vertical lines.BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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ferentially-expressed (50–60%). This reflects the
limitations of WISH as a secondary validation procedure
in these studies as the relative insensitivity of the method
fails to distinguish lower levels of differential expression.
While WISH gives spatial expression information in the
context of embryonic anatomy, our results suggest that
qPCR should be used as an additional tool to validate true
differential expression. In our hands, we detect differen-
tial expression for a large number of genes originally
ascribed as being not differentially-expressed by WISH.
We have uncovered a bias of differentially-expressed genes
towards the P-half-sclerotome, with the over-representa-
tion of factors involved in transcriptional regulation, and of
highly regulated cellular states such as phosphorylation
and differentiation. Collectively, this may indicate that the
development of the P-half-sclerotome is a more complex
and highly regulated process compared with A-half-scle-
rotome. While as expected, P-half-sclerotome differentially
expresses markers of bone and cartilage differentiation (e.g.
sox9), these are notably absent from A-cells. This finding
strongly supports the hypothesis that the central A-half-
sclerotome does not contribute bone and cartilage to the
vertebral column, promoting instead the development of
the segmental spinal nerves with associated sheath ele-
ments. The neural-associated fate of central-anterior cells
stands in striking contrast to that of dorsal- and ventral-
anterior cells, which are known contribute to the spinous
process and vertebral body respectively [2,12].
The dissected A-half sclerotomes used in our study will
include a range of somite stages some of which will be
expected to contain some neural crest cells that have
begun to migrate within the sclerotome. Consequently,
neural crest-expressed genes should be present within the
A-specific genes. In agreement with this, we found well-
established neural crest markers, such as crabp1  and
tcfap2/ap2 [35,36], within the 57 A-half sclerotome genes.
This would represent ~3.5% of the total A- specific genes.
More detailed expression studies will be required to deter-
mine whether any more A-specific genes (previously not
known to be expressed in neural crest cells) are also found
in neural crest. Other known neural crest-specific genes,
such as sox10 [37], have not been revealed in our analysis.
This might suggest that only a small proportion of neural
crest cells are found within the dissected portion of the A-
half-central sclerotome within the age-range of somites in
our sample, thereby diluting the expression of neural crest
markers with respect to all A-specific genes. Furthermore,
as our experiments examine expression differences
between A and P-half-sclerotomes, neural crest markers
that also have independent expression in the P-half will
be necessarily be absent.
A key property of the P-half-sclerotome is to repel the out-
growth of neural crest cells and spinal nerve (motor and
sensory) axons, thereby generating spinal nerve segmenta-
tion [21,25]. Candidate repellent molecules include
members of the semaphorin and ephrin families, and our
data have confirmed the P-specific expression of such
molecules. However, several previous studies have also
indicated that further P-specific repellents remain to be
identified [23,27], and our results provide a starting point
in this direction. Candidates warranting further investiga-
tion include the transmembrane semaphorin receptor
component, PlexinA2, which is prominently expressed in
the P-half-sclerotome and the cell surface heparan sul-
phate proteoglycan, glypican- 6 (gpc6). It is intriguing that
N-acetylgalactosaminyltransferase 4 (galnt4) appears high
in the candidate list (Additional File 5) since this enzyme
is essential for initiating O-glycosylation of glycoproteins,
and P-specific expression of an O-glycosylated peanut
agglutinin receptor protein is critical for axon repulsion
mediated by P-half-sclerotome cells [23].
Conclusion
We have profiled gene expression differences that define
the regional differentiation of the somite-derived scle-
rotome into anterior and posterior halves. Our data show
that several hundred genes are differentially-expressed
between the two halves. The results reveal a surprising
degree of molecular heterogeneity that underlies the
development of somite polarity, and indicate candidates
for further investigation as regulators of somite polarity
and vertebral morphogenesis, as well as repellents of spi-
nal axon growth.
Methods
Sclerotome dissection and RNA isolation
Strips of ~8 consecutive somites, corresponding to the 10–
18th most recently formed somites, of Theiler stage 15 (TS
[38]) mouse embryos (9.5–10.25 days post-coitum,
d.p.c.) were dissected into ice-cold Dulbecco's modified
Eagle's medium containing Hepes. Somite strips were
pinned medial-side-up with A5 insect pins, and transverse
cuts used to isolate the most anterior or posterior third of
the somite. A- or P-somite thirds were placed flat and all
tissue surrounding the central portion of the sclerotomal
mesenchyme was cut away using a 15° microfeather blade
(John Weiss Ltd). A- or P-sclerotome-thirds were trans-
ferred to a 1.5 ml microcentrifuge tube containing ~30 μl
RNAlater (Ambion) and total RNA was then isolated
using RNeasy spin columns (Qiagen). Somite thirds
rather than halves were used in order to minimize poten-
tial contamination of the samples. For consistency with
published literature we refer in the text to these samples as
having been isolated from somite halves.BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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RNA amplification, microarray hybridization and 
computation
Reverse transcription and initial RNA amplification were
performed using Super SMART cDNA synthesis (Clontech)
as described by the manufacturer, except that the 3' SMART
T7-RSAI-CDS-Oligo (dT) primer was replaced with a
primer of sequence- 5'-
AAGCAGTGGTATCAACGCAGAGTACGGCCAGTGAATT-
GTAATACGACTCACTAAGGGAGGCGGT(30)VN-3'
(Sigma), and cDNA amplification was limited to 18 cycles.
cDNA was purified using Nucleospin columns (BD Bio-
sciences). Labelled, amplified RNA (aRNA) was then syn-
thesized by in vitro transcription using the GeneChip® IVT-
Labelling kit (Affymetrix), and purified using RNAeasy spin
columns (Qiagen). RNA fragmentation and hybridization
to Mouse 430 GeneChip® microaarrays were performed as
described in the GeneChip® Expression Analysis Technical
Manual (Affymetrix) using an Affymetrix Hybridization
Oven 640 and a GeneChip® Fluidics Station 450. Arrays
were scanned using a GeneChip® Scanner 3000 7G, and
probe intensity data (.CEL files) generated from raw
scanned images (.DAT files) using the Microarray Suite soft-
ware package, MAS 5.0. The 'affy' package of Bioconductor
http://www.bioconductor.org was used to import probe
intensity data into the open-source R statistical environ-
ment http://cran.r-project.org/. Spatial artefacts were
screened using the heat map function of R. Sample integrity
was confirmed using MAS 5.0-generated 3'/5' probe inten-
sity ratios for β-actin and gapdh, and RNA digestion plots
were assessed using the Bioconductor 'affy' package. Model-
based inter- and intra- array outlier detection was per-
formed with dCHIP http://biosun1.har vard.edu/complab/
dchip/. Normalization was assessed using Bland-Altman
plots within R. Background adjustment, normalization and
expression measure were computed using the Bioconduc-
tor 'gcrma' package. For Welch's t-test, the t-test function of
Excel was used (Microsoft). Fisher's exact scores were gener-
ated by the R Fisher.test function. Further statistical analysis
was performed within R, and the Database for Annotation,
Visualization and Integrated Discovery (DAVID; http://
david.abcc.ncifcrf.gov/home.jsp).
Antisense RNA probe synthesis
PCR primers to generate unique probe templates for anti-
sense RNA synthesis, without significant homology to
other genome sequences, were designed using a semi-
automated Perl programme adapted from the Sanger
Institute microarray design pipeline (Robert Andrews,
Sanger Institute). Probe templates were generated by PCR
from whole mouse embryo cDNA using primers with the
T7 primer sequence (5'-TAATACGACTCACTATAGGGAG-
3') appended to the 5' end of the reverse primer. Digoxi-
genin-labeled probe was synthesized from the PCR prod-
uct using T7-mediated in vitro Megascript transcription
kits (Ambion). Labelled probes were purified using G50
gel filtration columns (Amersham).
Whole-mount mouse embryo in situ hybridization
Whole-mount  in situ hybridization (WISH) was per-
formed on TS15-17 (9.5–10.5 d.p.c.) mouse embryos
based on a protocol from Wilkinson [39] but adapted for
the InsituPro VS robotic liquid-handling system (Intavis
AG). Embryos were fixed for 48 hours in 10% neutral-
buffered formalin (NBF) and washed in PBS before dehy-
dration to methanol. Embryos were bleached for 1 hour
in 0.3% hydrogen peroxide/methanol before rehydration.
Permeabilization with 10 μg/ml proteinase K (Roche) in
PBST for 20–30 minutes was followed by quenching in
2% glycine/PBST, and fixation with 0.1% glutaraldehyde/
10% NBF. After PBST washing, embryos were rinsed in
hybridization buffer (0.1% triton X-100, 3× SSC, 1%
Roche blocking powder, 50% formamide, 0.1% CHAPS, 5
mM EDTA, 50 μ/ml heparin) prior to pre-hybridization at
62°C for 6 hours in fresh buffer. Samples were then
hybridised for 18 hours with the addition of digoxigenin-
labeled antisense probe (1 μg/ml). Post-hybridization
embryos were washed in 0.1% CHAPS, 2× SSC, 50% for-
mamide followed by 0.1% CHAPS, 0.2× SSC. After room
temperature washes in PBST, embryos were blocked in
20% goat serum/PBST followed by antibody incubation
(1/1000 Roche alkaline phosphatase-conjugated sheep
anti-digoxigenin fab fragments/10% goat serum/PBST)
for 6 hours. Embryos were washed 10 times in PBST, and
5 times in 100 mM Tris-HCl (pH 9.0), 100 mM NaCl,
0.1% triton X-100 before colour development using
BCIP/NBT (Roche).
Quantitative real-time PCR
Quantitative real-time PCR (qPCR) was performed using
an efficiency-corrected ΔCt method using SYBR® green on
an ABI 7500 Prism platform. Primers were designed to
span intron-exon boundaries using the open-source Perl-
Primer package (http://perlprimer.sourceforge.net/, see
Additional File 11). Only primer pairs with a correlation
coefficient of > 0.99 in a standard curve of Ct values plot-
ted against dilution, and a single peak on a dissociation
curve, were used. Gene expression measures were calcu-
lated from the geometric mean of 4–5 replicate readings
for each sample. Outliers with more than one standard
deviation from the mean Ct and replicates showing more
than 5% standard deviation from the mean Ct were
excluded. Gene expression for the gene of interest (GOI)
was normalized relative to β-actin using EGOI
(CtGOI)/Eβ-
actin
(Ct β-actin), where E = efficiency of amplification and is
derived from the standard curve (10(-1/slope)). To ensure
the identity of anterior- or posterior-half-sclerotomes,
uncx4.1 (a posterior-specific marker) expression relative
to β-actin was determined. Samples showing ΔΔCt > 10 or
<8 were considered as correctly dissected anterior or pos-
terior samples respectively. The relative expression of a
GOI was calculated from the RQ (relative quality) ratios
derived from the mean anterior and posterior ΔΔCt val-
ues. The lowest values of ΔΔCt (highest concentration)BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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were used to calculate the RQ ratios for the highest level
of differential expression between anterior and posterior
samples. Normalized graphical representation of qPCR
data (see Figure 7 & Additional File 10) were generated by
calculating Eβ-actin
(Ct β-actin)/EGOI
(Ct GOI) for each sample of a
GOI, and calculating all values as a percentage of the high-
est value (anterior or posterior) obtained for that gene.
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Additional file 1
Affymetrix identifiers and ranks for 11 known differentially-expressed 
sclerotome genes. Affymetrix identifiers of genes known to be differen-
tially-expressed in A- or P-half-sclerotome. Multiple entries for the same 
gene reflect the transcripts represented on the Affymetrix GeneChip (26 
transcripts corresponding to 11 genes, bold indicating the highest proba-
bility transcript for each gene). The probability of differential gene expres-
sion by Fisher's analysis, and the overall rank in array data are also listed.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-30-S1.doc]
Additional file 2
Further clustering of individual array experiments. Dendrograms for 
agglomerative hierarchical clustering of individual array hybridization 
experiments showing that arrays do not separate into A- or P-clusters when 
analysed against: (i) the whole genome (45,101 GeneChip transcripts); 
(ii) sclerotome-expressed genes without differential A-P expression (pax1, 
pax9, scleraxis); (iii) general somite markers (cdx1, etv5, fgf6, foxc1, 
foxc2, pax1, pax3, pax7, pax9, myoD, myogenin, myf5, scleraxis, 
sfrp2); or (iv) house-keeping genes (β-actin and gapdh).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-30-S2.pdf]
Additional file 3
Distribution of known transcripts amongst all rank-ordered tran-
scripts. (i) The distribution of 11 transcripts, with known differential 
expression between A- and P- half-sclerotome, shows that while most are 
evenly distributed across the rank-ordered transcripts, more than one-third 
fall within the cell representing the highest statistical certainty of differen-
tial expression (see Additional File 1 for transcript identifiers). (ii) In con-
trast, the distribution of genes with no differential expression within the 
sclerotome shows no such peak. Histograms were generated using the hist 
function of R with a cell number of 50.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-30-S3.pdf]
Additional file 4
Statistical significance of differential gene expression in the array 
data. The graph shows Fisher's exact score from Figure 4 for the range of 
0–1500 rank-ordered transcripts. See legend to Figure 4 for further 
description. The blue line corresponds to p = 10-7. Differential expression 
is highly significant for the top ~650 transcripts.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-30-S4.pdf]
Additional file 5
Differentially-expressed genes between A- and P-half-sclerotome 
(genes 1–175). Table showing rank order of probability of differentially 
expression in A- or P-half-sclerotome for the top 175 transcripts as deter-
mined by t-test.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-30-S5.xls]
Additional file 6
Differentially-expressed genes between A- and P-half-sclerotome 
(genes 176–850). Table showing rank order of probability of differen-
tially expression in A- or P-half-sclerotome for transcripts 176–850 as 
determined by t-test.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-30-S6.xls]
Additional file 7
Functional categorization of differentially-expressed genes. Table 
showing terms for biological processes that show a significant probability 
of enrichment relative to the genome for the first 175 genes as determined 
by DAVID.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-
213X-9-30-S7.xls]BMC Developmental Biology 2009, 9:30 http://www.biomedcentral.com/1471-213X/9/30
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Additional file 9
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